CS312691A3 - Process for preparing 5,11-dihydro-6h-dipyrido/3,2-b:2',3'-e//1,4/-diazepine derivatives - Google Patents

Process for preparing 5,11-dihydro-6h-dipyrido/3,2-b:2',3'-e//1,4/-diazepine derivatives Download PDF

Info

Publication number
CS312691A3
CS312691A3 CS913126A CS312691A CS312691A3 CS 312691 A3 CS312691 A3 CS 312691A3 CS 913126 A CS913126 A CS 913126A CS 312691 A CS312691 A CS 312691A CS 312691 A3 CS312691 A3 CS 312691A3
Authority
CS
Czechoslovakia
Prior art keywords
carbon atoms
alkyl
compound
formula
hydrogen
Prior art date
Application number
CS913126A
Other languages
Czech (cs)
English (en)
Inventor
Karl G Grozinger
Karl D Hargrave
Julian Adams
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of CS312691A3 publication Critical patent/CS312691A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CS913126A 1990-10-19 1991-10-15 Process for preparing 5,11-dihydro-6h-dipyrido/3,2-b:2',3'-e//1,4/-diazepine derivatives CS312691A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60045190A 1990-10-19 1990-10-19

Publications (1)

Publication Number Publication Date
CS312691A3 true CS312691A3 (en) 1992-05-13

Family

ID=24403650

Family Applications (1)

Application Number Title Priority Date Filing Date
CS913126A CS312691A3 (en) 1990-10-19 1991-10-15 Process for preparing 5,11-dihydro-6h-dipyrido/3,2-b:2',3'-e//1,4/-diazepine derivatives

Country Status (14)

Country Link
EP (1) EP0482481A1 (de)
JP (1) JPH05163272A (de)
KR (1) KR920008041A (de)
CA (1) CA2052946A1 (de)
CS (1) CS312691A3 (de)
FI (1) FI914923A7 (de)
HU (1) HU210678B (de)
IE (1) IE913662A1 (de)
NO (1) NO914102L (de)
NZ (1) NZ240279A (de)
PL (1) PL292097A1 (de)
PT (1) PT99273A (de)
YU (1) YU165891A (de)
ZA (1) ZA918335B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022531A1 (en) * 1991-06-11 1992-12-23 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the preparation of 3-amino-2-chloro-4-alkylpyridines
US5200522A (en) * 1991-06-11 1993-04-06 Boehringer Ingelheim Pharmaceuticals, Inc. Method for preparing 3-amino-2-chloro-4-alkylpyridines
DE4403311C1 (de) * 1994-02-03 1995-04-20 Boehringer Ingelheim Kg Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on)
CN113149896A (zh) * 2021-03-09 2021-07-23 利尔化学股份有限公司 一种3-氨基吡啶的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2424811C3 (de) * 1974-05-22 1981-08-20 Dr. Karl Thomae Gmbh, 7950 Biberach Pyrido-benzodiazepinone, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
IT1194766B (it) * 1981-03-10 1988-09-28 Crc Ricerca Chim Processo per la preparazione di 11-(2'-sostituito)-acetil-5,11-diidro-6h-pirido-(2,3-b)(1,4)-benzodiazepin-6-oni
DE3122670A1 (de) * 1981-06-06 1982-12-23 Dr. Karl Thomae Gmbh, 7950 Biberach "neue 1,4,9,10-tetrahydro-pyrazolo(4,3-e) pyrido(3,2-b)(1,4)diazepin-10-one, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von pharmazeutischen wirkstoffen"
DE3222809A1 (de) * 1981-07-15 1983-02-03 Dr. Karl Thomae Gmbh, 7950 Biberach Verfahren zur herstellung von 5,11-dihydro-6h-pyrido(2,3-b)-(1,4) benzodiazepin-6-onen
DK0393529T3 (da) * 1989-04-20 1993-11-15 Boehringer Ingelheim Pharma 5,11-Dihydro-6H-dipyrido(3,2-b:2,3-e)(1,4)diazepin-6-oner og deres anvendelse ved forhindring eller behandling af AIDS
EP0410148B1 (de) * 1989-06-28 1994-04-06 Boehringer Ingelheim Pharmaceuticals Inc. 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one und -thione und ihre Verwendung bei der AIDS-Vorbeugung oder -Behandlung

Also Published As

Publication number Publication date
NO914102L (no) 1992-04-21
FI914923A0 (fi) 1991-10-18
ZA918335B (en) 1992-09-30
JPH05163272A (ja) 1993-06-29
CA2052946A1 (en) 1992-04-20
AU8592491A (en) 1992-04-30
KR920008041A (ko) 1992-05-27
EP0482481A1 (de) 1992-04-29
HU210678B (en) 1995-06-28
HUT59408A (en) 1992-05-28
FI914923L (fi) 1992-04-20
FI914923A7 (fi) 1992-04-20
PT99273A (pt) 1992-08-31
YU165891A (sh) 1994-06-10
NZ240279A (en) 1993-12-23
AU646096B2 (en) 1994-02-10
IE913662A1 (en) 1992-04-22
PL292097A1 (en) 1992-07-13
NO914102D0 (no) 1991-10-18
HU913296D0 (en) 1992-01-28

Similar Documents

Publication Publication Date Title
AU640182B2 (en) N-(pyrrolo(2,3-d)pyrimidin-3-ylacyl)-glutamic acid derivatives
CA1216291A (en) Imidazoquinoxaline compounds
AU1371997A (en) Quinoline and quinazoline compounds useful in therapy
NO851862L (no) Fremgangsmaate ved fremstilling av nye pyrrolobenzimidazoler
US5466692A (en) Substituted pyridopyrimidines and antihypertensives
JPS62198683A (ja) 置換チエノイミダゾ−ル誘導体およびその製法
US5223503A (en) 6-substituted pyrido[2,3-d]pyrimidines as antineoplastic agents
NO793620L (no) Substituerte teofylliner, deres fremstilling og deres anvendelse
CA3128846A1 (en) Difluoromethylene compound
US4608384A (en) Thieno[2,3-b] pyrrole compounds and analgesic use thereof
CS244654B2 (en) Production method of in position 9 substituted derivatives of 4 oxo-4h-pyrido(1,2-a)pyrimidine
HU193923B (en) Process for preparing pyrimidine derivatives and pharmaceuticals comprising the same
CA1054600A (en) Amino derivatives of imidazo (4,5-b) pyridines
US4927828A (en) Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives
US5407940A (en) New ellipticine compounds
CS312691A3 (en) Process for preparing 5,11-dihydro-6h-dipyrido/3,2-b:2',3'-e//1,4/-diazepine derivatives
JPS6339878A (ja) ジアステレオマ−体テトラヒドロピリド〔2,3−d〕ピリミジン誘導体
US5571912A (en) Method for the preparation of 5,11-dihydro-6h-dipyrido [3,2-b:2',3'-e][1,4]diazepines
US4801590A (en) Pyrido(1,8)naphthyridinones, and their use as pharmaceuticals
JPH10287678A5 (de)
US20040092739A1 (en) Process for synthesizing antifolates
WO1988001270A1 (en) Pyridopyrimidinediones
NO137999B (no) Analogifremgangsm}te ved fremstilling av terapeutisk aktive oxofurylestere av 6-(alfa-aminofenylacetamido)-penicillansyre
EP3466948B1 (de) Kondensiertes pyrimidinpiperidinderivat sowie herstellungsverfahren und anwendung davon
CZ20013091A3 (cs) Opticky čisté analogy kamptothecinu